Top Story

Receipt of indomethacin did not affect risk for bronchopulmonary dysplasia, death in preterm infants

Receipt of indomethacin did not affect risk for bronchopulmonary dysplasia, death in preterm infants
April 27, 2015

SAN DIEGO — Prophylactic indomethacin did not reduce risk for bronchopulmonary dysplasia or death among extremely preterm infants, according to data presented at the Pediatric Academic Societies Annual Meeting.

To investigate associations between prophylactic indomethacin, bronchopulmonary dysplasia and death by 36 weeks gestational age, Erik Jensen, MD, of the Children’s Hospital of Philadelphia, and colleagues assessed infants with a gestational age of 29 weeks or less who were enrolled in the Neonatal Research Network Generic Database between 2008 and 2012. Receipt of supplemental oxygen at 36 weeks gestational age was considered bronchopulmonary dysplasia. The study cohort consisted of 2,671 infants who received prophylactic indomethacin and 5,368 who did not.

Medicare’s new payment system gives physicians two options Health Care Legislative and Regulatory Update

Medicare’s new payment system gives physicians two options

April 27, 2015
The Medicare Access and CHIP Reauthorization Act, signed into law on April 16, will make major changes in Medicare payments for physician services. Things start out…
In the Journals

Nitrofurantoin less effective than other antibiotics for UTI patients

April 27, 2015
Patients with urinary tract infection who were treated with nitrofurantoin appeared to experience greater incidence of treatment failure, regardless of kidney…

Weight-based vancomycin dosing could improve MRSA treatment in rural areas

April 27, 2015
In a rural setting, high rates of invasive MRSA bacteremia combined with limited antibiotic choices in the field may contribute to shorter courses of vancomycin…
Meeting News Coverage

NS5A RAVs may persist through 96 weeks after ledipasvir therapy

April 27, 2015
VIENNA — NS5A resistance-associated variants persisted through 96 weeks in a high proportion of patients treated with ledipasvir, an NS5A inhibitor, according to…
More News Headlines »
CME
Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

This activity is supported by an educational grant from Alcon Research, LTD.

More »
Meeting News Coverage Video
VIDEO: Effectiveness of inactivated vs. live flu vaccine currently unclear

VIDEO: Effectiveness of inactivated vs. live flu vaccine currently unclear

April 24, 2015
BETHESDA, Md. — Richard K. Zimmerman, MD, of the University of Pittsburgh, explains the results of his study…
More »
CME
Regimen Selection in HIV

Regimen Selection in HIV: Considering New Options to Optimize Outcomes
Monograph

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

More than 2 decades into the antiretroviral therapy (ART) era, numerous options are available for HIV treatment. The…
More »
morganatic-roan